Cabazitaxel

• Catalog No.: Cabazitaxel
• CAS Number: 183133-96-2
• M. F.: C45H57NO14
• M. W.: 835.93238

SYNONYMS

• IUPAC name: (1S,2S,3R,4S,7R,9S,10S,12R,15S)-4-(acetyloxy)-15-{[(2R,3S)-3-{[(tert-butoxy)carbonyl]amino}-2-hydroxy-3-phenylpropanoyl]oxy}-1-hydroxy-9,12-dimethoxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^3,^1^0.0^4,^7]heptadec-13-en-2-yl benzoate
• IUPAC Traditional name: cabazitaxel
• Brand Name: Jevtana

DATABASE IDS

• Wikipedia Title: Cabazitaxel
• Medline Plus: a611009
• CAS Number: 183133-96-2
• DrugBank ID: DB06772
• PubChem CID: 9854073
• CHEBI ID: 63584
• Unique Ingredient Identifier: 51F690397J
• Chemspider ID: 8029779
• ATC CODE: L01CD04
• CHEMBL: 1201748

PROPERTIES

• Admin Routes: Intravenous
• Legal Status: POM (UK)
• Legal Status: Rx-only (US)
• EU Licence: Jevtana
• US Licence: Cabazitaxel
• Pregnancy Category: D (US)